Touchon Pascal has filed 17 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 7828 shares of Atara Biotherapeutics, Inc. ($ATRA) on June 10, 2025.
Activity breakdown: 0 open-market purchases and 10 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 10, 2025 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | Not found | A | Common Stock | 7828 | $0.00 | 77,955.0000 | 7,488,000 | 11.16% | 0.10% |
| Aug. 16, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | S | Common Stock | 2762 | $6.63 | 70,403.0000 | 4,236,000 | 3.78% | 0.07% |
| Aug. 16, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | S | Common Stock | 276 | $6.63 | 70,127.0000 | 4,236,000 | 0.39% | 0.01% |
| Aug. 12, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | D | Employee Stock Option (Right to Buy) | 9000 | $0.00 | 0.0000 | 4,236,000 | 100.00% | 0.21% |
| Aug. 12, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | D | Employee Stock Option (Right to Buy) | 9680 | $0.00 | 0.0000 | 4,236,000 | 100.00% | 0.23% |
| Aug. 12, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | D | Employee Stock Option (Right to Buy) | 7075 | $0.00 | 0.0000 | 4,236,000 | 100.00% | 0.17% |
| May 16, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | S | Common Stock | 81506 | $0.62 | 1,829,146.0000 | 4,236,000 | 4.27% | 1.92% |
| March 4, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | S | Common Stock | 24844 | $0.72 | 1,910,652.0000 | 4,236,000 | 1.28% | 0.59% |
| Jan. 8, 2024 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | A | Common Stock | 1280000 | $0.00 | 1,935,496.0000 | 4,236,000 | 195.27% | 30.22% |
| Nov. 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | S | Common Stock | 20409 | $0.39 | 655,496.0000 | 0 | 3.02% | 0.00% |
| Aug. 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | S | Common Stock | 21432 | $1.65 | 685,239.0000 | 0 | 3.03% | 0.00% |
| Aug. 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | S | Common Stock | 9334 | $1.65 | 675,905.0000 | 0 | 1.36% | 0.00% |
| June 27, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | S | Common Stock | 14291 | $1.66 | 706,671.0000 | 0 | 1.98% | 0.00% |
| May 16, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | S | Common Stock | 29766 | $2.04 | 720,962.0000 | 0 | 3.96% | 0.00% |
| March 2, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | S | Common Stock | 15679 | $3.63 | 750,728.0000 | 0 | 2.05% | 0.00% |
| March 1, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | A | Common Stock | 324711 | $0.00 | 766,407.0000 | 0 | 73.51% | 0.00% |
| March 1, 2023 | Atara Biotherapeutics, Inc. | $ATRA | Touchon Pascal | President and CEO | A | Employee Stock Option (Right to Buy) | 730600 | $0.00 | 730,600.0000 | 0 | 9999.99% | 0.00% |